{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T01:58:00Z","timestamp":1789091880540,"version":"build-2803163510"},"reference-count":65,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T00:00:00Z","timestamp":1675382400000},"content-version":"am","delay-in-days":339,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006436","name":"Bristol-Myers Squibb Co Summit","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006436","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009947","name":"Merck Sharp & Dohme Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalnutritionjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.clnu.2022.01.016","type":"journal-article","created":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T10:54:00Z","timestamp":1643021640000},"page":"610-619","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Elevated coffee consumption is associated with a lower risk of elevated liver fibrosis biomarkers in patients treated for chronic hepatitis B (ANRS CO22 Hepather cohort)"],"prefix":"10.1016","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3439-8868","authenticated-orcid":false,"given":"Tangui","family":"Barr\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Fontaine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9mence","family":"Ramier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6252-8316","authenticated-orcid":false,"given":"Vincent","family":"Di Beo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanislas","family":"Pol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6794-4837","authenticated-orcid":false,"given":"Patrizia","family":"Carrieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabienne","family":"Marcellin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Cagnot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Dorival","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Zucman-Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabien","family":"Zoulim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8672-7918","authenticated-orcid":false,"given":"Fabrice","family":"Carrat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0164-7917","authenticated-orcid":false,"given":"Camelia","family":"Protopopescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.clnu.2022.01.016_bib1","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1001\/jama.2018.3795","article-title":"Chronic hepatitis B infection: a review","volume":"319","author":"Tang","year":"2018","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.clnu.2022.01.016_bib2","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S2468-1253(19)30349-8","article-title":"The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"5","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"12","key":"10.1016\/j.clnu.2022.01.016_bib3","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1002\/ijc.31280","article-title":"Fraction and incidence of liver cancer attributable to hepatitis B and C viruses worldwide","volume":"142","author":"Maucort-Boulch","year":"2018","journal-title":"Int J Cancer"},{"issue":"11","key":"10.1016\/j.clnu.2022.01.016_bib4","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1111\/apt.14619","article-title":"Fibrosis-4 index predicts cirrhosis risk and liver-related mortality in 2075 patients with chronic HBV infection","volume":"47","author":"Tseng","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"issue":"10","key":"10.1016\/j.clnu.2022.01.016_bib5","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1097\/MCG.0000000000000574","article-title":"Noninvasive tests for fibrosis predict 5-year mortality and hepatocellular carcinoma in patients with chronic hepatitis B","volume":"50","author":"Kim","year":"2016","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"11","key":"10.1016\/j.clnu.2022.01.016_bib6","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S2468-1253(19)30190-6","article-title":"Targets and future direct-acting antiviral approaches to achieve hepatitis B virus cure","volume":"4","author":"Asselah","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.clnu.2022.01.016_bib7","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jhep.2020.04.013","article-title":"Hepatitis B surface antigen seroclearance: immune mechanisms, clinical impact, importance for drug development","volume":"73","author":"Tout","year":"2020","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.clnu.2022.01.016_bib8","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/jvh.13471","article-title":"Durability of hepatitis B surface antigen seroclearance and subsequent risk for hepatocellular carcinoma: a meta-analysis","volume":"28","author":"Song","year":"2021","journal-title":"J\u00a0Viral Hepat"},{"issue":"Suppl 1","key":"10.1016\/j.clnu.2022.01.016_bib9","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/liv.12710","article-title":"Reversibility of hepatitis B virus cirrhosis after therapy: who and why?","volume":"35","author":"Bedossa","year":"2015","journal-title":"Liver Int"},{"issue":"8","key":"10.1016\/j.clnu.2022.01.016_bib10","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1111\/liv.14108","article-title":"Impacts of cigarette smoking on liver fibrosis and its regression under therapy in male patients with chronic hepatitis B","volume":"39","author":"Xiong","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.clnu.2022.01.016_bib11","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-020-09783-2","article-title":"Socioeconomic and marital status among liver cirrhosis patients and associations with mortality: a population-based cohort study in Sweden","volume":"20","author":"Vaz","year":"2020","journal-title":"BMC Publ Health"},{"key":"10.1016\/j.clnu.2022.01.016_bib12","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1471-230X-9-35","article-title":"Socioeconomic status and survival of cirrhosis patients: a Danish nationwide cohort study","volume":"9","author":"Jepsen","year":"2009","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.clnu.2022.01.016_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jnutbio.2017.11.003","article-title":"Food components with antifibrotic activity and implications in prevention of liver disease","volume":"55","author":"Bae","year":"2018","journal-title":"J\u00a0Nutr Biochem"},{"key":"10.1016\/j.clnu.2022.01.016_bib14","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2147\/DMSO.S198744","article-title":"Dietary patterns in relation to hepatic fibrosis among patients with nonalcoholic fatty liver disease","volume":"12","author":"Soleimani","year":"2019","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"3","key":"10.1016\/j.clnu.2022.01.016_bib15","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s12020-020-02268-7","article-title":"Insulin resistance is related with liver fibrosis in type 2 diabetic patients with non-alcoholic fatty liver disease proven biopsy and Mediterranean diet pattern as a protective factor","volume":"68","author":"Aller","year":"2020","journal-title":"Endocrine"},{"issue":"4","key":"10.1016\/j.clnu.2022.01.016_bib16","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.jhep.2017.10.025","article-title":"The impact of coffee consumption on fibrosis and steatosis in HIV-HCV co-infected patients","volume":"68","author":"Carrieri","year":"2018","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.clnu.2022.01.016_bib17","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jhep.2016.08.021","article-title":"Safety and efficacy of daclatasvir-sofosbuvir in HCV genotype 1-mono-infected patients","volume":"66","author":"Pol","year":"2017","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.clnu.2022.01.016_bib18","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/jhep.2003.50346","article-title":"A\u00a0simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C","volume":"38","author":"Wai","year":"2003","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.clnu.2022.01.016_bib19","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling Richard","year":"2006","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.clnu.2022.01.016_bib20","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/hep.27382","article-title":"Comparison of diagnostic accuracy of aspartate aminotransferase to platelet ratio index and fibrosis-4 index for detecting liver fibrosis in adult patients with chronic hepatitis B virus infection: a systemic review and meta-analysis","volume":"61","author":"Xiao","year":"2015","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.clnu.2022.01.016_bib21","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1365-2036.2008.03895.x","article-title":"The accuracy of the FIB-4 index for the diagnosis of mild fibrosis in chronic hepatitis B","volume":"29","author":"Mallet","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"issue":"8","key":"10.1016\/j.clnu.2022.01.016_bib22","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1136\/gutjnl-2015-309260","article-title":"The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa","volume":"65","author":"Lemoine","year":"2016","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.clnu.2022.01.016_bib24","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/biomet\/80.1.27","article-title":"Bias reduction of maximum likelihood estimates","volume":"80","author":"Firth","year":"1993","journal-title":"Biometrika"},{"key":"10.1016\/j.clnu.2022.01.016_bib25","author":"Hosmer"},{"issue":"11","key":"10.1016\/j.clnu.2022.01.016_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0113677","article-title":"Augmented backward elimination: a pragmatic and purposeful way to develop statistical models","volume":"9","author":"Dunkler","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.clnu.2022.01.016_bib27","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"67","author":"Lampertico","year":"2017","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1016\/j.clnu.2022.01.016_bib28","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1080\/09674845.2018.1459147","article-title":"The gamma-glutamyl transferase to platelet ratio and the FIB-4 score are noninvasive markers to determine the severity of liver fibrosis in chronic hepatitis B infection","volume":"75","author":"Lee","year":"2018","journal-title":"Br J Biomed Sci"},{"issue":"8","key":"10.1016\/j.clnu.2022.01.016_bib29","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.medmal.2019.02.004","article-title":"A\u00a0new combined predicting model using a non-invasive score for the assessment of liver fibrosis in patients presenting with chronic hepatitis B virus infection","volume":"49","author":"Ben Ayed","year":"2019","journal-title":"Med Maladies Infect"},{"issue":"50","key":"10.1016\/j.clnu.2022.01.016_bib30","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000018319","article-title":"Gamma-glutamyl transpeptidase-to-platelet ratio and the fibrosis-4 index in predicting hepatitis B virus-related hepatocellular carcinoma development in elderly chronic hepatitis B patients in China: a single-center retrospective study","volume":"98","author":"Zhu","year":"2019","journal-title":"Medicine (Baltim)"},{"issue":"2","key":"10.1016\/j.clnu.2022.01.016_bib31","doi-asserted-by":"crossref","DOI":"10.1097\/MEG.0000000000000776","article-title":"Coffee consumption and risk of nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"29","author":"Wijarnpreecha","year":"2017","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.clnu.2022.01.016_bib32","doi-asserted-by":"crossref","first-page":"100254","DOI":"10.1016\/j.aohep.2020.08.071","article-title":"The effect of coffee consumption on the non-alcoholic fatty liver disease and liver fibrosis: a meta-analysis of 11 epidemiological studies","volume":"20","author":"Hayat","year":"2021","journal-title":"Ann Hepatol"},{"issue":"11","key":"10.1016\/j.clnu.2022.01.016_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142457","article-title":"Coffee consumption decreases risks for hepatic fibrosis and cirrhosis: a meta-analysis","volume":"10","author":"Liu","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.clnu.2022.01.016_bib34","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3390\/nu9010056","article-title":"Coffee intake is associated with a lower liver stiffness in patients with non-alcoholic fatty liver disease, Hepatitis C, and Hepatitis B","volume":"9","author":"Hodge","year":"2017","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.clnu.2022.01.016_bib35","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.jfma.2018.08.002","article-title":"Association of coffee consumption and liver fibrosis progression in patients with HBeAg-negative chronic hepatitis B: a 5-year population-based cohort study","volume":"118","author":"Chen","year":"2019","journal-title":"J\u00a0Formos Med Assoc"},{"issue":"1","key":"10.1016\/j.clnu.2022.01.016_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3727\/105221617X15046391179559","article-title":"Coffee consumption and prevention of cirrhosis: in support of the caffeine hypothesis","volume":"18","author":"Dranoff","year":"2018","journal-title":"Gene Expr"},{"issue":"2","key":"10.1016\/j.clnu.2022.01.016_bib37","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/hep.27032","article-title":"HOW does coffee prevent liver fibrosis? Biological plausibility for recent epidemiological observations","volume":"60","author":"Dranoff","year":"2014","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.clnu.2022.01.016_bib38","first-page":"389","article-title":"Chronic inflammatory liver diseases and coffee intake","volume":"22","author":"Contaldo","year":"2019","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"4","key":"10.1016\/j.clnu.2022.01.016_bib39","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.3390\/nu13041314","article-title":"The role of fructose in non-alcoholic steatohepatitis: old relationship and new insights","volume":"13","author":"Federico","year":"2021","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.clnu.2022.01.016_bib40","first-page":"179","article-title":"Caffeine content and antioxidant activity of various brews of specialty grade coffee","volume":"20","author":"Mi\u0142ek","year":"2021","journal-title":"Acta Sci Pol Technol Aliment"},{"issue":"3","key":"10.1016\/j.clnu.2022.01.016_bib41","first-page":"205","article-title":"Caffeine content of beverages as consumed","volume":"114","author":"Gilbert","year":"1976","journal-title":"Can Med Assoc J"},{"issue":"7","key":"10.1016\/j.clnu.2022.01.016_bib42","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.1021\/jf0101410","article-title":"Comparison of the antioxidant activity of commonly consumed polyphenolic beverages (coffee, cocoa, and tea) prepared per cup serving","volume":"49","author":"Richelle","year":"2001","journal-title":"J\u00a0Agric Food Chem"},{"issue":"2","key":"10.1016\/j.clnu.2022.01.016_bib43","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jhep.2017.03.013","article-title":"Coffee and herbal tea consumption is associated with lower liver stiffness in the general population: the Rotterdam study","volume":"67","author":"Alferink","year":"2017","journal-title":"J\u00a0Hepatol"},{"issue":"8","key":"10.1016\/j.clnu.2022.01.016_bib44","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.cgh.2015.01.030","article-title":"Coffee and caffeine are associated with decreased risk of advanced hepatic fibrosis among patients with hepatitis C","volume":"13","author":"Khalaf","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"11","key":"10.1016\/j.clnu.2022.01.016_bib45","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1002\/jmv.24243","article-title":"Gender differences in chronic HBsAg carriers in Italy: evidence for the independent role of male sex in severity of liver disease","volume":"87","author":"Stroffolini","year":"2015","journal-title":"J\u00a0Med Virol"},{"issue":"10","key":"10.1016\/j.clnu.2022.01.016_bib46","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000085","article-title":"Influence of gender and reproductive factors on liver fibrosis in patients with chronic hepatitis B infection","volume":"10","author":"Xiong","year":"2019","journal-title":"Clin Transl Gastroenterol"},{"issue":"2","key":"10.1016\/j.clnu.2022.01.016_bib47","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/hep.26385","article-title":"Prediction models of long-term cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients: risk scores integrating host and virus profiles","volume":"58","author":"Lee","year":"2013","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.clnu.2022.01.016_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0175482","article-title":"No contribution of lifestyle and environmental exposures to gender discrepancy of liver disease severity in chronic hepatitis b infection: observations from the Haimen City cohort","volume":"12","author":"Sun","year":"2017","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.clnu.2022.01.016_bib49","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1055\/s-0029-1214376","article-title":"Alcohol and liver fibrosis","volume":"29","author":"Cubero","year":"2009","journal-title":"Semin Liver Dis"},{"issue":"9","key":"10.1016\/j.clnu.2022.01.016_bib50","doi-asserted-by":"crossref","first-page":"883","DOI":"10.3748\/wjg.v26.i9.883","article-title":"Role of alcohol in pathogenesis of hepatitis B virus infection","volume":"26","author":"Ganesan","year":"2020","journal-title":"World J Gastroenterol"},{"issue":"8","key":"10.1016\/j.clnu.2022.01.016_bib51","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/ijc.31181","article-title":"Interaction between tobacco smoking and hepatitis B virus infection on the risk of liver cancer in a Chinese population","volume":"142","author":"Liu","year":"2018","journal-title":"Int J Cancer"},{"issue":"4","key":"10.1016\/j.clnu.2022.01.016_bib52","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1002\/hep.30339","article-title":"Smoking and hepatitis B virus-related hepatocellular carcinoma risk: the mediating roles of viral load and alanine aminotransferase","volume":"69","author":"Wang","year":"2019","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.clnu.2022.01.016_bib53","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.aohep.2020.01.005","article-title":"Alcohol, tobacco and coffee consumption and liver disease severity among individuals with Chronic Hepatitis B infection in North America","volume":"19","author":"Brahmania","year":"2020","journal-title":"Ann Hepatol"},{"issue":"12","key":"10.1016\/j.clnu.2022.01.016_bib54","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1001\/jama.2010.297","article-title":"Association of socioeconomic position with health behaviors and mortality","volume":"303","author":"Stringhini","year":"2010","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.clnu.2022.01.016_bib55","article-title":"Socio-economic determinants of physical activity across the life course: a \u00ab DEterminants of DIet and Physical ACtivity \u00bb (DEDIPAC) umbrella literature review","volume":"13","author":"O'Donoghue","year":"2018","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.clnu.2022.01.016_bib56","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/nutrit\/nuv027","article-title":"Contribution of food prices and diet cost to socioeconomic disparities in diet quality and health: a systematic review and analysis","volume":"73","author":"Darmon","year":"2015","journal-title":"Nutr Rev"},{"issue":"3","key":"10.1016\/j.clnu.2022.01.016_bib57","article-title":"Physical activity is associated with reduced risk of liver disease in the prospective UK Biobank cohort","volume":"3","author":"Schneider","year":"2021","journal-title":"JHEP Rep"},{"issue":"3","key":"10.1016\/j.clnu.2022.01.016_bib58","article-title":"Phytocannabinoids-A green approach toward non-alcoholic fatty liver disease treatment","volume":"10","author":"Berk","year":"2021","journal-title":"J\u00a0Clin Med"},{"issue":"2","key":"10.1016\/j.clnu.2022.01.016_bib59","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/MEG.0000000000001263","article-title":"Marijuana is not associated with progression of hepatic fibrosis in liver disease: a systematic review and meta-analysis","volume":"31","author":"Farooqui","year":"2019","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.clnu.2022.01.016_bib60","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/jebm.12317","article-title":"Use of cannabis and risk of advanced liver fibrosis in patients with chronic hepatitis C virus infection: a systematic review and meta-analysis","volume":"11","author":"Wijarnpreecha","year":"2018","journal-title":"J\u00a0Evid Base Med"},{"key":"10.1016\/j.clnu.2022.01.016_bib61","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1749-6632.2011.06202.x","article-title":"Socioeconomic status and smoking: a review","volume":"1248","author":"Hiscock","year":"2012","journal-title":"Ann N Y Acad Sci"},{"issue":"8","key":"10.1016\/j.clnu.2022.01.016_bib62","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.cgh.2007.06.015","article-title":"Risk and predictors of mortality associated with chronic hepatitis B infection","volume":"5","author":"Iloeje","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.clnu.2022.01.016_bib63","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-027696","article-title":"Chronic hepatitis B virus infection and total and cause-specific mortality: a prospective cohort study of 0.5 million people","volume":"9","author":"Si","year":"2019","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.clnu.2022.01.016_bib64","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.pcad.2018.02.002","article-title":"Coffee for cardioprotection and longevity","volume":"61","author":"O'Keefe","year":"2018","journal-title":"Prog Cardiovasc Dis"},{"issue":"6","key":"10.1016\/j.clnu.2022.01.016_bib65","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1002\/hep.27367","article-title":"Inverse associations of total and decaffeinated coffee with liver enzyme levels in NHANES 1999\u20132010","volume":"60","author":"Xiao","year":"2014","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.clnu.2022.01.016_bib66","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-013739","article-title":"Coffee, including caffeinated and decaffeinated coffee, and the risk of hepatocellular carcinoma: a systematic review and dose\u2013response meta-analysis","volume":"7","author":"Kennedy","year":"2017","journal-title":"BMJ Open"}],"container-title":["Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561422000255?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561422000255?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T01:04:17Z","timestamp":1759367057000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0261561422000255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":65,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S0261561422000255"],"URL":"https:\/\/doi.org\/10.1016\/j.clnu.2022.01.016","relation":{},"ISSN":["0261-5614"],"issn-type":[{"value":"0261-5614","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elevated coffee consumption is associated with a lower risk of elevated liver fibrosis biomarkers in patients treated for chronic hepatitis B (ANRS CO22 Hepather cohort)","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnu.2022.01.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.","name":"copyright","label":"Copyright"}]}}